Drugs and Devices

FDA approves first quadrivalent vaccine to prevent seasonal influenza

On Feb. 29, the U.S. Food and Drug Administration (FDA) announced the approval of FluMist Quadrivalent, the first influenza vaccine to contain four strains of the influenza virus, two influenza A strains and two influenza B strains. FluMist Quadrivalent is deigned to prevent seasonal influenza in people ages 2 years through 49 years. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Newsletter Subscribe

  • This field is for validation purposes and should be left unchanged.

Test Your Nursing Knowledge

Answer this interactive quiz to be entered to win a gift card.

  • This field is for validation purposes and should be left unchanged.

Insights Blog

Today’s News in Nursing

Shares